Victor Perlroth, Kodiak Sciences CEO
February 23, 2022 07:27 AM EST
R&D

Ko­di­ak’s Eylea con­tender falls flat in PhI­II, wip­ing out near­ly $2B in val­ue

Jason Mast

Editor

Last Ju­ly, Ko­di­ak Sci­ences turned down a $125 mil­lion pay­ment from the in­vest­ment firm Bak­er Bros. The sec­ond and fi­nal in­stall­ment from a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Im­munol­o­gy biotech In­ma­gene to join Nas­daq through re­verse merg­er with what's left of Ike­na

A service from the Financial Times